55
Views
18
CrossRef citations to date
0
Altmetric
Article

Loss of von Hippel-Lindau Protein (VHL) Increases Systemic Cholesterol Levels through Targeting Hypoxia-Inducible Factor 2α and Regulation of Bile Acid Homeostasis

, , , , , , & show all
Pages 1208-1220 | Received 29 Oct 2013, Accepted 08 Jan 2014, Published online: 20 Mar 2023

REFERENCES

  • Summons RE, Bradley AS, Jahnke LL, Waldbauer JR. 2006. Steroids, triterpenoids and molecular oxygen. Philos. Trans. R. Soc. Lond. B Biol. Sci. 361:951–968. http://dx.doi.org/10.1098/rstb.2006.1837.
  • Sherpa LY, Deji Stigum H, Chongsuvivatwong V, Luobu O, Thelle DS, Nafstad P, Bjertness E. 2011. Lipid profile and its association with risk factors for coronary heart disease in the highlanders of Lhasa, Tibet. High Alt. Med. Biol. 12:57–63. http://dx.doi.org/10.1089/ham.2010.1050.
  • Michailidis V, Steiropoulos P, Nena E, Papanas N, Maltezos E, Bouros D. 2011. Continuous positive airway pressure treatment: effect on serum lipids in patients with obstructive sleep apnoea. Open Cardiovasc. Med. J. 5:231–238. http://dx.doi.org/10.2174/1874192401105010231.
  • Robinson GV, Pepperell JC, Segal HC, Davies RJ, Stradling JR. 2004. Circulating cardiovascular risk factors in obstructive sleep apnoea: data from randomised controlled trials. Thorax 59:777–782. http://dx.doi.org/10.1136/thx.2003.018739.
  • Sanner BM, Fluerenbrock N, Kleiber-Imbeck A, Mueller JB, Zidek W. 2001. Effect of continuous positive airway pressure therapy on infectious complications in patients with obstructive sleep apnea syndrome. Respiration 68:483–487. http://dx.doi.org/10.1159/000050555.
  • Fang G, Song D, Ye X, Mao SZ, Liu G, Liu SF. 2012. Chronic intermittent hypoxia exposure induces atherosclerosis in ApoE knockout mice: role of NF-kappaB p50. Am. J. Pathol. 181:1530–1539. http://dx.doi.org/10.1016/j.ajpath.2012.07.024.
  • Jun J, Reinke C, Bedja D, Berkowitz D, Bevans-Fonti S, Li J, Barouch LA, Gabrielson K, Polotsky VY. 2010. Effect of intermittent hypoxia on atherosclerosis in apolipoprotein E-deficient mice. Atherosclerosis 209:381–386. http://dx.doi.org/10.1016/j.atherosclerosis.2009.10.017.
  • Drager LF, Jun J, Polotsky VY. 2010. Obstructive sleep apnea and dyslipidemia: implications for atherosclerosis. Curr. Opin. Endocrinol. Diabetes Obes. 17:161–165. http://dx.doi.org/10.1097/MED.0b013e3283373624.
  • Qu A, Taylor M, Xue X, Matsubara T, Metzger D, Chambon P, Gonzalez FJ, Shah YM. 2011. Hypoxia-inducible transcription factor 2alpha promotes steatohepatitis through augmenting lipid accumulation, inflammation, and fibrosis. Hepatology 54:472–483. http://dx.doi.org/10.1002/hep.24400.
  • Wang GL, Jiang BH, Rue EA, Semenza GL. 1995. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc. Natl. Acad. Sci. U. S. A. 92:5510–5514. http://dx.doi.org/10.1073/pnas.92.12.5510.
  • Haase VH, Glickman JN, Socolovsky M, Jaenisch R. 2001. Vascular tumors in livers with targeted inactivation of the von Hippel-Lindau tumor suppressor. Proc. Natl. Acad. Sci. U. S. A. 98:1583–1588. http://dx.doi.org/10.1073/pnas.98.4.1583.
  • Kim JW, Tchernyshyov I, Semenza GL, Dang CV. 2006. HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. Cell Metab. 3:177–185. http://dx.doi.org/10.1016/j.cmet.2006.02.002.
  • Rankin EB, Rha J, Selak MA, Unger TL, Keith B, Liu Q, Haase VH. 2009. Hypoxia-inducible factor 2 regulates hepatic lipid metabolism. Mol. Cell. Biol. 29:4527–4538. http://dx.doi.org/10.1128/MCB.00200-09.
  • Rankin EB, Rha J, Unger TL, Wu CH, Shutt HP, Johnson RS, Simon MC, Keith B, Haase VH. 2008. Hypoxia-inducible factor-2 regulates vascular tumorigenesis in mice. Oncogene 27:5354–5358. http://dx.doi.org/10.1038/onc.2008.160.
  • Albers JJ, Bierman EL. 1976. The effect of hypoxia on uptake and degradation of low density lipoproteins by cultured human arterial smooth muscle cells. Biochim. Biophys. Acta 424:422–429. http://dx.doi.org/10.1016/0005-2760(76)90031-X.
  • Mukodani J, Ishikawa Y, Fukuzaki H. 1990. Effects of hypoxia on sterol synthesis, acyl-CoA:cholesterol acyltransferase activity, and efflux of cholesterol in cultured rabbit skin fibroblasts. Arteriosclerosis 10:106–110. http://dx.doi.org/10.1161/01.ATV.10.1.106.
  • Raghavendran K, Davidson BA, Helinski JD, Marschke CJ, Manderscheid P, Woytash JA, Notter RH, Knight PR. 2005. A rat model for isolated bilateral lung contusion from blunt chest trauma. Anesth. Analg. 101:1482–1489. http://dx.doi.org/10.1213/01.ANE.0000180201.25746.1F.
  • Safran M, Kim WY, O'Connell F, Flippin L, Gunzler V, Horner JW, Depinho RA, Kaelin WGJr. 2006. Mouse model for noninvasive imaging of HIF prolyl hydroxylase activity: assessment of an oral agent that stimulates erythropoietin production. Proc. Natl. Acad. Sci. U. S. A. 103:105–110. http://dx.doi.org/10.1073/pnas.0509459103.
  • Shah YM, Ito S, Morimura K, Chen C, Yim SH, Haase VH, Gonzalez FJ. 2008. Hypoxia-inducible factor augments experimental colitis through an MIF-dependent inflammatory signaling cascade. Gastroenterology 134:2036–2048. http://dx.doi.org/10.1053/j.gastro.2008.03.009.
  • Shah YM, Matsubara T, Ito S, Yim SH, Gonzalez FJ. 2009. Intestinal hypoxia-inducible transcription factors are essential for iron absorption following iron deficiency. Cell Metab. 9:152–164. http://dx.doi.org/10.1016/j.cmet.2008.12.012.
  • Taylor M, Qu A, Anderson ER, Matsubara T, Martin A, Gonzalez FJ, Shah YM. 2011. Hypoxia-inducible factor-2alpha mediates the adaptive increase of intestinal ferroportin during iron deficiency in mice. Gastroenterology 140:2044–2055. http://dx.doi.org/10.1053/j.gastro.2011.03.007.
  • Xue X, Taylor M, Anderson E, Hao C, Qu A, Greenson JK, Zimmermann EM, Gonzalez FJ, Shah YM. 2012. Hypoxia-inducible factor-2alpha activation promotes colorectal cancer progression by dysregulating iron homeostasis. Cancer Res. 72:2285–2293. http://dx.doi.org/10.1158/0008-5472.CAN-11-3836.
  • Anderson ER, Taylor M, Xue X, Martin A, Moons DS, Omary MB, Shah YM. 2012. The hypoxia-inducible factor-C/EBPalpha axis controls ethanol-mediated hepcidin repression. Mol. Cell. Biol. 32:4068–4077. http://dx.doi.org/10.1128/MCB.00723-12.
  • Qu A, Shah YM, Manna SK, Gonzalez FJ. 2012. Disruption of endothelial peroxisome proliferator-activated receptor gamma accelerates diet-induced atherogenesis in LDL receptor-null mice. Arterioscler. Thromb. Vasc. Biol. 32:65–73. http://dx.doi.org/10.1161/ATVBAHA.111.239137.
  • Cheng J, Krausz KW, Li F, Ma X, Gonzalez FJ. 2013. CYP2E1-dependent elevation of serum cholesterol, triglycerides, and hepatic bile acids by isoniazid. Toxicol. Appl. Pharmacol. 266:245–253. http://dx.doi.org/10.1016/j.taap.2012.10.024.
  • Kim I, Ahn SH, Inagaki T, Choi M, Ito S, Guo GL, Kliewer SA, Gonzalez FJ. 2007. Differential regulation of bile acid homeostasis by the farnesoid X receptor in liver and intestine. J. Lipid Res. 48:2664–2672. http://dx.doi.org/10.1194/jlr.M700330-JLR200.
  • Ivan M, Kondo K, Yang H, Kim W, Valiando J, Ohh M, Salic A, Asara JM, Lane WS, Kaelin WGJr. 2001. HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science 292:464–468. http://dx.doi.org/10.1126/science.1059817.
  • Jaakkola P, Mole DR, Tian YM, Wilson MI, Gielbert J, Gaskell SJ, von Kriegsheim A, Hebestreit HF, Mukherji M, Schofield CJ, Maxwell PH, Pugh CW, Ratcliffe PJ. 2001. Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science 292:468–472. http://dx.doi.org/10.1126/science.1059796.
  • Brown MS, Goldstein JL. 1997. The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell 89:331–340. http://dx.doi.org/10.1016/S0092-8674(00)80213-5.
  • Bricker LA, Weis HJ, Siperstein MD. 1972. In vivo demonstration of the cholesterol feedback system by means of a desmosterol suppression technique. J. Clin. Investig. 51:197–205. http://dx.doi.org/10.1172/JCI106804.
  • Goldstein JL, Brown MS. 2009. The LDL receptor. Arterioscler. Thromb. Vasc. Biol. 29:431–438. http://dx.doi.org/10.1161/ATVBAHA.108.179564.
  • Ma PT, Gil G, Sudhof TC, Bilheimer DW, Goldstein JL, Brown MS. 1986. Mevinolin, an inhibitor of cholesterol synthesis, induces mRNA for low density lipoprotein receptor in livers of hamsters and rabbits. Proc. Natl. Acad. Sci. U. S. A. 83:8370–8374. http://dx.doi.org/10.1073/pnas.83.21.8370.
  • Russell DW, Yamamoto T, Schneider WJ, Slaughter CJ, Brown MS, Goldstein JL. 1983. cDNA cloning of the bovine low density lipoprotein receptor: feedback regulation of a receptor mRNA. Proc. Natl. Acad. Sci. U. S. A. 80:7501–7505. http://dx.doi.org/10.1073/pnas.80.24.7501.
  • Levy E, Spahis S, Sinnett D, Peretti N, Maupas-Schwalm F, Delvin E, Lambert M, Lavoie MA. 2007. Intestinal cholesterol transport proteins: an update and beyond. Curr. Opin. Lipidol. 18:310–318. http://dx.doi.org/10.1097/MOL.0b013e32813fa2e2.
  • Saraswathi V, Gao L, Morrow JD, Chait A, Niswender KD, Hasty AH. 2007. Fish oil increases cholesterol storage in white adipose tissue with concomitant decreases in inflammation, hepatic steatosis, and atherosclerosis in mice. J. Nutr. 137:1776–1782.
  • Swaner JC, Connor WE. 1975. Hypercholesterolemia of total starvation: its mechanism via tissue mobilization of cholesterol. Am. J. Physiol. 229:365–369.
  • Duane WC. 2009. Bile acids: developments new and very old. J. Lipid Res. 50:1507–1508. http://dx.doi.org/10.1194/jlr.E900004-JLR200.
  • Chai J, He Y, Cai SY, Jiang Z, Wang H, Li Q, Chen L, Peng Z, He X, Wu X, Xiao T, Wang R, Boyer JL, Chen W. 2012. Elevated hepatic multidrug resistance-associated protein 3/ATP-binding cassette subfamily C 3 expression in human obstructive cholestasis is mediated through tumor necrosis factor alpha and c-Jun NH2-terminal kinase/stress-activated protein kinase-signaling pathway. Hepatology 55:1485–1494. http://dx.doi.org/10.1002/hep.24801.
  • Li T, Jahan A, Chiang JY. 2006. Bile acids and cytokines inhibit the human cholesterol 7 alpha-hydroxylase gene via the JNK/c-jun pathway in human liver cells. Hepatology 43:1202–1210. http://dx.doi.org/10.1002/hep.21183.
  • Kir S, Zhang Y, Gerard RD, Kliewer SA, Mangelsdorf DJ. 2012. Nuclear receptors HNF4alpha and LRH-1 cooperate in regulating Cyp7a1 in vivo. J. Biol. Chem. 287:41334–41341. http://dx.doi.org/10.1074/jbc.M112.421834.
  • Noshiro M, Usui E, Kawamoto T, Kubo H, Fujimoto K, Furukawa M, Honma S, Makishima M, Honma K, Kato Y. 2007. Multiple mechanisms regulate circadian expression of the gene for cholesterol 7alpha-hydroxylase (Cyp7a), a key enzyme in hepatic bile acid biosynthesis. J. Biol. Rhythms 22:299–311. http://dx.doi.org/10.1177/0748730407302461.
  • Duez H, van der Veen JN, Duhem C, Pourcet B, Touvier T, Fontaine C, Derudas B, Bauge E, Havinga R, Bloks VW, Wolters H, van der Sluijs FH, Vennstrom B, Kuipers F, Staels B. 2008. Regulation of bile acid synthesis by the nuclear receptor Rev-erbalpha. Gastroenterology 135:689–698. http://dx.doi.org/10.1053/j.gastro.2008.05.035.
  • Le Martelot G, Claudel T, Gatfield D, Schaad O, Kornmann B, Lo Sasso G, Moschetta A, Schibler U. 2009. REV-ERBalpha participates in circadian SREBP signaling and bile acid homeostasis. PLoS Biol. 7:e1000181. http://dx.doi.org/10.1371/journal.pbio.1000181.
  • Li F, Jiang C, Krausz KW, Li Y, Albert I, Hao H, Fabre KM, Mitchell JB, Patterson AD, Gonzalez FJ. 2013. Microbiome remodelling leads to inhibition of intestinal farnesoid X receptor signalling and decreased obesity. Nat. Commun. 4:2384. http://dx.doi.org/10.1038/ncomms3384.
  • Sayin SI, Wahlstrom A, Felin J, Jantti S, Marschall HU, Bamberg K, Angelin B, Hyotylainen T, Oresic M, Backhed F. 2013. Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist. Cell Metab. 17:225–235. http://dx.doi.org/10.1016/j.cmet.2013.01.003.
  • Chiang JY, Kimmel R, Weinberger C, Stroup D. 2000. Farnesoid X receptor responds to bile acids and represses cholesterol 7alpha-hydroxylase gene (CYP7A1) transcription. J. Biol. Chem. 275:10918–10924. http://dx.doi.org/10.1074/jbc.275.15.10918.
  • Sinal CJ, Tohkin M, Miyata M, Ward JM, Lambert G, Gonzalez FJ. 2000. Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis. Cell 102:731–744. http://dx.doi.org/10.1016/S0092-8674(00)00062-3.
  • Hu CJ, Wang LY, Chodosh LA, Keith B, Simon MC. 2003. Differential roles of hypoxia-inducible factor 1alpha (HIF-1alpha) and HIF-2alpha in hypoxic gene regulation. Mol. Cell. Biol. 23:9361–9374. http://dx.doi.org/10.1128/MCB.23.24.9361-9374.2003.
  • Raghavendran K, Notter RH, Davidson BA, Helinski JD, Kunkel SL, Knight PR. 2009. Lung contusion: inflammatory mechanisms and interaction with other injuries. Shock 32:122–130. http://dx.doi.org/10.1097/SHK.0b013e31819c385c.
  • Galea AM, Brown AJ. 2009. Special relationship between sterols and oxygen: were sterols an adaptation to aerobic life? Free Radic. Biol. Med. 47:880–889. http://dx.doi.org/10.1016/j.freeradbiomed.2009.06.027.
  • Li T, Francl JM, Boehme S, Chiang JY. 2013. Regulation of cholesterol and bile acid homeostasis by the CYP7A1/SREBP2/miR-33a axis. Hepatology 58:1111–1121. http://dx.doi.org/10.1002/hep.26427.
  • Li T, Matozel M, Boehme S, Kong B, Nilsson LM, Guo G, Ellis E, Chiang JY. 2011. Overexpression of cholesterol 7alpha-hydroxylase promotes hepatic bile acid synthesis and secretion and maintains cholesterol homeostasis. Hepatology 53:996–1006. http://dx.doi.org/10.1002/hep.24107.
  • Schwarz M, Russell DW, Dietschy JM, Turley SD. 1998. Marked reduction in bile acid synthesis in cholesterol 7alpha-hydroxylase-deficient mice does not lead to diminished tissue cholesterol turnover or to hypercholesterolemia. J. Lipid Res. 39:1833–1843.
  • Drager LF, Polotsky VY, Lorenzi-Filho G. 2011. Obstructive sleep apnea: an emerging risk factor for atherosclerosis. Chest 140:534–542. http://dx.doi.org/10.1378/chest.10-2223.
  • Bostrom P, Magnusson B, Svensson PA, Wiklund O, Boren J, Carlsson LM, Stahlman M, Olofsson SO, Hulten LM. 2006. Hypoxia converts human macrophages into triglyceride-loaded foam cells. Arterioscler. Thromb. Vasc. Biol. 26:1871–1876. http://dx.doi.org/10.1161/01.ATV.0000229665.78997.0b.
  • Jiang G, Li T, Qiu Y, Rui Y, Chen W, Lou Y. 2007. RNA interference for HIF-1alpha inhibits foam cells formation in vitro. Eur. J. Pharmacol. 562:183–190. http://dx.doi.org/10.1016/j.ejphar.2007.01.066.
  • Drager LF, Yao Q, Hernandez KL, Shin MK, Bevans-Fonti S, Gay J, Sussan TE, Jun JC, Myers AC, Olivecrona G, Schwartz AR, Halberg N, Scherer PE, Semenza GL, Powell DR, Polotsky VY. 2013. Chronic intermittent hypoxia induces atherosclerosis via activation of adipose angiopoietin-like 4. Am. J. Respir. Crit. Care Med. 188:240–248. http://dx.doi.org/10.1164/rccm.201209-1688OC.
  • Xue X, Ramakrishnan S, Anderson E, Taylor M, Zimmermann EM, Spence JR, Huang S, Greenson JK, Shah YM. 2013. Endothelial PAS domain protein 1 activates the inflammatory response in the intestinal epithelium to promote colitis in mice. Gastroenterology 145:831–841. http://dx.doi.org/10.1053/j.gastro.2013.07.010.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.